See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2020_Eagle_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000827871, Eagle Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 179,449,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 55,326,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,202,000 |
| 3 | remainder_Assets | 17,577,000 |
| 4 | LiabilitiesCurrent | 38,823,000 |
| 5 | LiabilitiesNoncurrent | 36,557,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 47,864,475 |
| 8 | SellingGeneralAndAdministrativeExpense | 89,498,759 |
| 9 | ResearchAndDevelopmentExpense | 36,722,651 |
| 10 | remainder_Expenses | 21,845,683 |
| 11 | remainder_Revenues | 172,263,798 |
| 12 | remainder_NetIncome | -1,183,785 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 254,554,000 |
| 1 | Liabilities | 75,380,000 |
| 2 | Expenses | 195,931,568 |
| 3 | Revenues | 172,263,798 |
| 4 | StockholdersEquity | 179,174,000 |
| 5 | NetIncome | -24,851,555 |
| 6 | ComprehensiveNetIncome | -24,851,555 |
| 7 | BaseVar | 349,656,576 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.22 |
| 9 | EconomicCapitalRatio | 3.17 |
Edgar->Model Mapping
Feature Distribution
Change over Time
